COMPOSITION FOR KILLING TNF-alpha-SENSITIVE TUMOR CELLS

FIELD: medicine. SUBSTANCE: composition has cytostatic agent and TNF-alpha. Preparations intercollating into DNA is taken as the cytostatic agent and biologically active mouramylpeptide is added. Mass proportions of the cytostatic agent, muramylpeptide and TNF -alpha is 1:0.06 - 300:0.00001 - 0.1. E...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ANDRONOVA T.M, PETROVA E.EH, NESMEJANOV V.A, VALJAKINA T.I
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine. SUBSTANCE: composition has cytostatic agent and TNF-alpha. Preparations intercollating into DNA is taken as the cytostatic agent and biologically active mouramylpeptide is added. Mass proportions of the cytostatic agent, muramylpeptide and TNF -alpha is 1:0.06 - 300:0.00001 - 0.1. EFFECT: enhanced effectiveness of treatment.